Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
05/2012
05/03/2012US20120108586 Arthropod pest control method and composition
05/03/2012US20120108585 Benzoxazoles, benzthiazoles and related analogs as sirtuin modulators
05/03/2012US20120108584 2h or 3h-benzo[e]indazol-1-yl carbamate derivatives, the preparation and therapeutic use thereof
05/03/2012US20120108579 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
05/03/2012US20120108578 INHIBITORS OF 11beta-HYDROXYSTEROID DEHYDROGENASE 1
05/03/2012US20120108575 Heterocyclic-substituted piperidine compounds and the uses thereof
05/03/2012US20120108573 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
05/03/2012US20120108572 Novel benzamides, production thereof, and use thereof as medicaments
05/03/2012US20120108566 Nicotinamides as jak kinase modulators
05/03/2012US20120108565 Pyrrole carboxylic acid derivatives as antibacterial agents
05/03/2012US20120107273 New piperazine compound and use thereof as a hcv polymerase inhibitor
05/03/2012US20120107271 Ethynyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
05/03/2012CA2816188A1 Substituted phenoxypyridines
05/03/2012CA2815910A1 Alpha-7 nicotinic receptor modulators for the treatment of pain, a psychotic disorder, cognitive impairment or alzheimer's disease
05/03/2012CA2814846A1 Cyclic amine substituted oxazolidinone cetp inhibitor
05/03/2012CA2814768A1 Oxazoline and isoxazoline derivatives as crac modulators
05/03/2012CA2814752A1 Diazeniumdiolate heterocyclic derivatives
05/03/2012CA2814436A1 Polymorphs and salts of 6-(1h-indol-4-yl)-4-(5-{[4-(1-methylethyl)-1-piperazinyl]methyl}-1,3-oxazol-2-yl)-1h-indazole as pi3k inhibitors for use in the treatment of e.g. respiratory disorders
05/02/2012EP2447264A1 N-substituted-cyclic amino derivative
05/02/2012EP2445906A1 Insecticidal compounds
05/02/2012EP2445905A1 Polymerizable ambipolar hosts for phosphorescent guest emitters
05/02/2012EP2445904A1 Novel gpr 119 agonists
05/02/2012EP2445903A1 1, 3-disubstituted imidazolidin-2-one derivatives as inhibitors of cyp 17
05/02/2012EP2445892A1 5-membered heteroaryl derivatives used as sphingosine 1-phosphate receptor agonists
05/02/2012EP2445891A1 5-membered heteroaryl derivatives used as sphingosine 1-phosphate receptor agonists
05/02/2012EP2445889A1 Novel oxazolone and pyrrolidinone-substituted arylamides
05/02/2012EP2445887A2 Novel azabicyclohexanes
05/02/2012EP2445886A1 Heterocyclic compounds and their uses
05/02/2012EP2445878A1 New compounds, pharmaceutical composition and methods relating thereto
05/02/2012EP1955697B1 2-aminobenzamide derivatives as vanilloid receptor 1 (vr1) inhibitors useful for the treatment of pain or bladder function disorder
05/02/2012EP1785415B1 Piperidine derivative or pharmaceutically acceptable salt thereof
05/02/2012EP1748045B1 Light-emitting device material and light-emitting device
05/02/2012EP1730152B1 Tetrahydroquinoline derivatives and a process for preparing the same
05/02/2012EP1627869B1 Vanilloid receptor modulators
05/02/2012EP1606264B1 Monocyclic anilide spirohydantoin cgrp receptor antagonists
05/02/2012CN102439007A Amide derivative
05/02/2012CN102439006A Crystalline form of r)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate
05/02/2012CN102439005A Novel substituted indazole and aza-indazole derivatives as gamma secretase modulators
05/02/2012CN102438990A Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
05/02/2012CN102438989A Novel oxazolone and pyrrolidinone-substituted arylamides
05/02/2012CN102438988A Resorcinol derivatives as hsp90 inhibitors
05/02/2012CN102438985A Substituted piperidines as par-1 antagonists
05/02/2012CN102432598A Tricyclic compound, preparation method thereof and pharmaceutical application thereof
05/02/2012CN102432552A Quinazoline analogs as receptor tyrosine kinase inhibitors
05/02/2012CN101812059B Nitric oxide donor-type farnesyl thiosalicylic acid derivative, and preparation method and medical application thereof
05/02/2012CN101184758B Novel compounds
05/02/2012CN101065363B Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
05/01/2012US8168797 Oxazolidinone derivative with difluorophenyl moiety, pharmaceutically acceptable salt thereof, preparation method thereof and antibiotic composition containing the same as an active ingredient
05/01/2012US8168794 Pim kinase inhibitors and methods of their use
05/01/2012US8168793 Nitrocatechol derivatives as COMT inhibitors
05/01/2012US8168785 Benzothiazole derivatives
05/01/2012US8168784 Processes to make apoptosis promoters
05/01/2012US8168672 Thioamide derivatives as progesterone receptor modulators
05/01/2012US8168653 Mediators of hedgehog signaling pathways, compositions and uses related thereto
05/01/2012US8168634 Thiazole derivatives as kinase inhibitors
05/01/2012US8168627 Helix 12 directed non-steroidal antiandrogens
05/01/2012CA2623332C Carboxamide derivatives as muscarinic receptor antagonists
05/01/2012CA2556669C Hepatitis c inhibitor peptide analogs
05/01/2012CA2517888C Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
05/01/2012CA2509413C Benzazepine derivatives for the treatment of neurological disorders
05/01/2012CA2439604C N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation
05/01/2012CA2437579C Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester
04/2012
04/26/2012WO2012054510A1 Oxadiazole compounds which inhibit beta-secretase activity and methods of use thereof
04/26/2012WO2012054333A2 Methods for identifying inhibitors of abeta42 oligomers
04/26/2012WO2012053606A1 Arylaminoheterocyclic carboxamide compound
04/26/2012WO2012053186A1 Arylamide derivatives as ttx-s blockers
04/26/2012WO2012052948A1 Pyridine- 2- derivatives as smoothened receptor modulators
04/26/2012WO2012052489A1 1-(heterocyclic carbonyl) piperidines
04/26/2012WO2012052420A1 Method for preparing substituted n-(3-amino-quinoxalin-2-yl)-sulfonamides and their intermediates n-(3-chloro-quinoxalin-2-yl)sulfonamides
04/26/2012WO2012052412A1 Novel heterocyclic compounds as pesticides
04/26/2012WO2012052410A1 Novel substituted picolinic acids, salts and acid derivatives thereof, and use thereof as herbicides
04/26/2012WO2012052395A1 Isoxazole derivatives used as oestrogen modulators
04/26/2012WO2012052390A1 N-2-(2-pyridinyl)-4-pyrimidinyl-beta-alanine derivatives as inhibitors of histone demethylase jmjd3
04/26/2012WO2012052167A1 Substituted 6-amino-nicotinamides as kcnq2/3 modulators
04/26/2012WO2012051692A1 Processes for the preparation of rivaroxaban and intermediates thereof
04/26/2012WO2012002680A3 2-pyridyl substituted imidazoles as therapeutic alk5 and/or alk4 inhibitors
04/26/2012WO2011159129A3 Novel rhodanine derivatives, method for preparing same, and pharmaceutical composition for the prevention or treatment of aids containing the rhodanine derivatives as active ingredients
04/26/2012US20120101138 Fluorinated aminotriazole derivatives
04/26/2012US20120101134 5-membered heteroaryl derivatives used as sphingosine 1-phosphate receptor agonists
04/26/2012US20120101131 Aminotetrahydroindazoloacetic Acids
04/26/2012US20120101124 1,2,4-oxadiazol derivatives, their pharmaceutical compositions and their use as sphingosine 1-phosphate 1 receptor agonists
04/26/2012US20120101111 Novel oxazolidinone deriviatives
04/26/2012US20120101109 Ethanolamine salt of n- (3-methoxy-5-methylpyrazin-2yl) -2- (4-[1, 3, 4-oxadiazole-2-yl] phenyl) pyridine-3- sulphonamide
04/26/2012US20120101105 Aryl substituted carboxamide derivatives as calcium or sodium channel blockers
04/26/2012US20120101100 Heterocyclic urea derivatives and methods of use thereof-211
04/26/2012US20120101099 Histone deacetylase inhibitors
04/26/2012US20120101098 3,28-disubstituted betulinic acid derivatives as anti-hiv agents
04/26/2012US20120101097 Aryl sulfonamides
04/26/2012US20120101092 Small molecule inhibitors of mdm2 and the uses thereof
04/26/2012US20120101091 Viral polymerase inhibitors
04/26/2012US20120101083 S1p1 agonists comprising a bicyclic n-containing ring
04/26/2012US20120101080 Composition for treatment of tuberculosis
04/26/2012US20120101079 Substituted 6-amino-nicotinamides as kcnq2/3 modulators
04/26/2012US20120101078 Amide derivatives as neuropeptide y5 receptor ligands
04/26/2012US20120101072 Triazole compounds that modulate hsp90 activity
04/26/2012US20120101064 Imidazole derivatives and their use as modulators of cyclin dependent kinases
04/26/2012US20120100991 Herbicidal benzoxazinones
04/26/2012US20120100989 3-Aryl-4-(2-thienylmethylene)isoxazol-5(4H)-ones as Fungicides
04/26/2012US20120100078 Pyrazine Derivatives and Uses Thereof in Renal Monitoring
04/26/2012US20120097929 Heterocyclic compound and organic light-emitting device including the same
1 ... 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 ... 647